Department of Neurosurgery, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Department of Neurosurgery, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
World Neurosurg. 2024 May;185:e1268-e1279. doi: 10.1016/j.wneu.2024.03.067. Epub 2024 Mar 19.
Using a laboratory-based optical setup, we show that 5-aminolevulinic acid (5ALA) fluorescence is better detected using the endoscope than the microscope. Furthermore, we present our case series of fully endoscopic 5ALA-guided resection of intraparenchymal tumors.
A Zeiss Pentero microscope was compared with the Karl Storz Hopkins endoscope. The spectra and intensity of each blue light source were measured. Quantitative fluorescence detection thresholds were measured using a spectrometer. Subjective fluorescence detection thresholds were measured by 6 blinded neuro-oncology surgeons. Clinical data were prospectively collected for all consecutive cases of fully endoscopic 5ALA-guided resection of intraparenchymal tumors between 2012 and 2023.
The intensity of blue light on the sample was greater for the endoscope than the microscope at working distances less than 20 mm. The quantitative fluorescence detection thresholds were lower for the endoscope than the microscope at both 30-/10-mm working distances. Fluorescence detection threshold was 0.65%-0.80% relative 4-dicyanomethylene-2-methyl-6-p-dimethylaminostyryl-4H-pyranthe concentration (3.20 × 10 to 3.94 × 10mol/dm) for the microscope, 0.40%-0.55% relative concentrations (1.97 × 10 to 2.71 × 10mol/dm) for the endoscope at 30 mm, and 0.15%-0.30% relative concentrations (7.40 × 10 to 1.48 × 10mol/dm) for the endoscope at 10 mm. In total, 49 5ALA endoscope-assisted brain tumor resections were carried out on 45 patients (mean age = 41 years, male = 28). Greater than 95% resection was achieved in 80% of cases and gross total resection in 42%. Gross total resection was achieved in 100% of tumors in noneloquent locations. There was 1 new neurologic deficit.
The endoscope provides enhanced visualization/detection of 5ALA-induced fluorescence compared with the microscope. 5ALA endoscopic-assisted resection of intraparenchymal tumors is safe and feasible.
我们使用基于实验室的光学设置证明,与显微镜相比,内窥镜更能检测到 5-氨基酮戊酸(5ALA)的荧光。此外,我们还介绍了完全内窥镜下使用 5ALA 引导切除脑实质内肿瘤的病例系列。
将蔡司 Pentero 显微镜与卡尔史托斯 Hopkins 内窥镜进行比较。测量每个蓝光光源的光谱和强度。使用光谱仪测量定量荧光检测阈值。6 名盲法神经肿瘤外科医生测量主观荧光检测阈值。2012 年至 2023 年期间,前瞻性收集了所有连续接受完全内窥镜下使用 5ALA 引导切除脑实质内肿瘤的病例的临床数据。
在工作距离小于 20mm 时,与显微镜相比,内窥镜上的样本蓝光强度更大。在 30mm 和 10mm 工作距离下,内窥镜的定量荧光检测阈值均低于显微镜。显微镜荧光检测阈值为 0.65%-0.80%相对 4-二氰基-2-甲基-6-对二甲氨基苯乙烯-4H-吡喃浓度(3.20×10至 3.94×10mol/dm),30mm 时内窥镜为 0.40%-0.55%相对浓度(1.97×10至 2.71×10mol/dm),10mm 时内窥镜为 0.15%-0.30%相对浓度(7.40×10至 1.48×10mol/dm)。共对 45 名患者的 49 例 5ALA 内窥镜辅助脑肿瘤切除术进行了分析(平均年龄为 41 岁,男性为 28 岁)。80%的病例达到了大于 95%的切除率,42%达到了大体全切除。非语言区的肿瘤 100%达到大体全切除。有 1 例新的神经功能缺损。
与显微镜相比,内窥镜提供了增强的 5ALA 诱导荧光的可视化/检测。5ALA 内窥镜辅助切除脑实质内肿瘤是安全可行的。